These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25147157)

  • 41. Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.
    Rijnink EC; Teng YKO; Wilhelmus S; Almekinders M; Wolterbeek R; Cransberg K; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2017 May; 12(5):734-743. PubMed ID: 28473317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of a renal risk score in a cohort of ANCA-associated vasculitis patients with severe kidney damage.
    Mejía-Vilet JM; Martín-Nares E; Cano-Verduzco ML; Pérez-Arias AA; Sedano-Montoya MA; Hinojosa-Azaola A
    Clin Rheumatol; 2020 Jun; 39(6):1935-1943. PubMed ID: 31970548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
    Hogan SL; Nachman PH; Wilkman AS; Jennette JC; Falk RJ
    J Am Soc Nephrol; 1996 Jan; 7(1):23-32. PubMed ID: 8808106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathology of the ANCA-associated vasculitides].
    Ferrario F; Vanzati A; Pilla D; Pagni F
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis.
    Lim JH; Han MH; Kim YJ; Jeon Y; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Lee H; Kim DK; Moon KC; Park SH
    PLoS One; 2020; 15(7):e0236051. PubMed ID: 32716952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of Japanese MPO-ANCA-related nephritis: significance of initial renal death for survival.
    Watanabe K; Tani Y; Kimura H; Tanaka K; Hayashi Y; Asahi K; Sato K; Sato M; Matsushima M; Nakayama M; Watanabe T
    Intern Med; 2012; 51(15):1969-76. PubMed ID: 22864120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
    Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
    Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.
    Kaplan-Pavlovcic S; Cerk K; Kveder R; Lindic J; Vizjak A
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v5-7. PubMed ID: 12817057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathologic classification of ANCA-associated glomerulonephritis.
    Berden AE; Ferrario F; Hagen EC; Jayne DR; Jennette JC; Joh K; Neumann I; Noël LH; Pusey CD; Waldherr R; Bruijn JA; Bajema IM
    J Am Soc Nephrol; 2010 Oct; 21(10):1628-36. PubMed ID: 20616173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Tennstedt P; Vettorazzi E; Busch M; Nitschke M; Jabs WJ; Özcan F; Wendt R; Hausberg M; Sellin L; Panzer U; Huber TB; Waldherr R; Hopfer H; Stahl RAK; Wiech T
    Kidney Int; 2018 Dec; 94(6):1177-1188. PubMed ID: 30385041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
    Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.
    Bjørneklett R; Bostad L; Fismen AS
    Biomed Res Int; 2018; 2018():7581567. PubMed ID: 29955611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study.
    Choudhury TA; Singh RG; ; Singh S; Singh TB; Rathore SS;
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):689-96. PubMed ID: 24821180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crescentic glomerulonephritis in children.
    Mayer U; Schmitz J; Bräsen JH; Pape L
    Pediatr Nephrol; 2020 May; 35(5):829-842. PubMed ID: 32052153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis.
    Kurita N; Mise N; Fujii A; Mori M; Sai K; Nishi T; Suzuki T; Tagawa H; Sugimoto T
    Clin Exp Nephrol; 2010 Aug; 14(4):325-32. PubMed ID: 20339893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosis.
    Hanaoka H; Ota Y; Takeuchi T; Kuwana M
    Clin Rheumatol; 2016 Feb; 35(2):495-500. PubMed ID: 26742758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.
    Cerqueira DC; Soares CM; Silva VR; Magalhães JO; Barcelos IP; Duarte MG; Pinheiro SV; Colosimo EA; Simões e Silva AC; Oliveira EA
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):728-35. PubMed ID: 24458086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome.
    Ellis CL; Manno RL; Havill JP; Racusen LC; Geetha D
    BMC Nephrol; 2013 Oct; 14():210. PubMed ID: 24093336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.